X
Boehringer files for new rare disease use for nintedanib in EU, US
https://pharmaphorum.com/news/boehringer-files-for-new-rare-disease-use-for-nintedanib-in-eu-us/
IPF
Biomarker trial to show drug value in rare lung disease
Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.